Cargando…
The effectiveness and value of gene therapy for hemophilia: A Summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387967/ https://www.ncbi.nlm.nih.gov/pubmed/37121251 http://dx.doi.org/10.18553/jmcp.2023.29.5.576 |
_version_ | 1785082003708706816 |
---|---|
author | Tice, Jeffrey A Walton, Surrey M Sarker, Jyotirmoy Moradi, Ashton Chu, Janet N Herce-Hagiwara, Belen Fahim, Shahariar Mohammed Agboola, Foluso Rind, David Pearson, Steven D |
author_facet | Tice, Jeffrey A Walton, Surrey M Sarker, Jyotirmoy Moradi, Ashton Chu, Janet N Herce-Hagiwara, Belen Fahim, Shahariar Mohammed Agboola, Foluso Rind, David Pearson, Steven D |
author_sort | Tice, Jeffrey A |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10387967 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Academy of Managed Care Pharmacy |
record_format | MEDLINE/PubMed |
spelling | pubmed-103879672023-07-31 The effectiveness and value of gene therapy for hemophilia: A Summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum Tice, Jeffrey A Walton, Surrey M Sarker, Jyotirmoy Moradi, Ashton Chu, Janet N Herce-Hagiwara, Belen Fahim, Shahariar Mohammed Agboola, Foluso Rind, David Pearson, Steven D J Manag Care Spec Pharm Perspectives on Value Academy of Managed Care Pharmacy 2023-05 /pmc/articles/PMC10387967/ /pubmed/37121251 http://dx.doi.org/10.18553/jmcp.2023.29.5.576 Text en Copyright © 2023, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Perspectives on Value Tice, Jeffrey A Walton, Surrey M Sarker, Jyotirmoy Moradi, Ashton Chu, Janet N Herce-Hagiwara, Belen Fahim, Shahariar Mohammed Agboola, Foluso Rind, David Pearson, Steven D The effectiveness and value of gene therapy for hemophilia: A Summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum |
title | The effectiveness and value of gene therapy for hemophilia: A Summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum |
title_full | The effectiveness and value of gene therapy for hemophilia: A Summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum |
title_fullStr | The effectiveness and value of gene therapy for hemophilia: A Summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum |
title_full_unstemmed | The effectiveness and value of gene therapy for hemophilia: A Summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum |
title_short | The effectiveness and value of gene therapy for hemophilia: A Summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum |
title_sort | effectiveness and value of gene therapy for hemophilia: a summary from the institute for clinical and economic review’s california technology assessment forum |
topic | Perspectives on Value |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387967/ https://www.ncbi.nlm.nih.gov/pubmed/37121251 http://dx.doi.org/10.18553/jmcp.2023.29.5.576 |
work_keys_str_mv | AT ticejeffreya theeffectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT waltonsurreym theeffectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT sarkerjyotirmoy theeffectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT moradiashton theeffectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT chujanetn theeffectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT hercehagiwarabelen theeffectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT fahimshahariarmohammed theeffectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT agboolafoluso theeffectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT rinddavid theeffectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT pearsonstevend theeffectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT ticejeffreya effectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT waltonsurreym effectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT sarkerjyotirmoy effectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT moradiashton effectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT chujanetn effectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT hercehagiwarabelen effectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT fahimshahariarmohammed effectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT agboolafoluso effectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT rinddavid effectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT pearsonstevend effectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum |